Stereotactische mono-radiotherapie per cyberknife voor vroeg stadium prostaatkanker: Een nieuwe behandelmethode

S. Aluwini; P. H.E. Van Rooij; I. K. Kolkman-Deurloo; C. H. Bangma

Stereotactische mono-radiotherapie per cyberknife voor vroeg stadium prostaatkanker: Een nieuwe behandelmethode

Translated title of the contribution: Cyberknife stereotactic radiotherapy as monotherapy for low to intermediate stage prostate cancer: Early experience, feasibility and tolerance

S. Aluwini^*, P. H.E. Van Rooij, I. K. Kolkman-Deurloo, C. H. Bangma

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The Cyberknife, a linear accelerator mounted on a robotic device, enables excellent dose conformation to the target and minimizes dose to surrounding normal tissue. It is a very suitable device for performing hypofractionated stereotactic body radiotherapy (SBRT) as monotherapy for low to intermediate risk prostate cancer patients. We report our early experience using this technique.

Translated title of the contribution	Cyberknife stereotactic radiotherapy as monotherapy for low to intermediate stage prostate cancer: Early experience, feasibility and tolerance
Original language	Dutch
Pages (from-to)	27-30
Number of pages	4
Journal	Nederlands Tijdschrift voor Urologie
Volume	18
Issue number	1
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{72d61249dbd54388b4904d68fa03e564,

title = "Stereotactische mono-radiotherapie per cyberknife voor vroeg stadium prostaatkanker: Een nieuwe behandelmethode",

abstract = "The Cyberknife, a linear accelerator mounted on a robotic device, enables excellent dose conformation to the target and minimizes dose to surrounding normal tissue. It is a very suitable device for performing hypofractionated stereotactic body radiotherapy (SBRT) as monotherapy for low to intermediate risk prostate cancer patients. We report our early experience using this technique.",

author = "S. Aluwini and {Van Rooij}, {P. H.E.} and Kolkman-Deurloo, {I. K.} and Bangma, {C. H.}",

year = "2010",

language = "Dutch",

volume = "18",

pages = "27--30",

number = "1",

}

TY - JOUR

T1 - Stereotactische mono-radiotherapie per cyberknife voor vroeg stadium prostaatkanker

T2 - Een nieuwe behandelmethode

AU - Aluwini, S.

AU - Van Rooij, P. H.E.

AU - Kolkman-Deurloo, I. K.

AU - Bangma, C. H.

PY - 2010

Y1 - 2010

N2 - The Cyberknife, a linear accelerator mounted on a robotic device, enables excellent dose conformation to the target and minimizes dose to surrounding normal tissue. It is a very suitable device for performing hypofractionated stereotactic body radiotherapy (SBRT) as monotherapy for low to intermediate risk prostate cancer patients. We report our early experience using this technique.

AB - The Cyberknife, a linear accelerator mounted on a robotic device, enables excellent dose conformation to the target and minimizes dose to surrounding normal tissue. It is a very suitable device for performing hypofractionated stereotactic body radiotherapy (SBRT) as monotherapy for low to intermediate risk prostate cancer patients. We report our early experience using this technique.

UR - http://www.scopus.com/inward/record.url?scp=77649253083&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77649253083

SN - 0929-0184

VL - 18

SP - 27

EP - 30

JO - Nederlands Tijdschrift voor Urologie

JF - Nederlands Tijdschrift voor Urologie

IS - 1

ER -

Stereotactische mono-radiotherapie per cyberknife voor vroeg stadium prostaatkanker: Een nieuwe behandelmethode

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this